MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
about
MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and SurvivinMiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro.Upregulating miR-146a by physcion reverses multidrug resistance in human chronic myelogenous leukemia K562/ADM cells.MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek's disease lymphoma cell proliferation and migration.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.The role of miR-130a in cancer.MicroRNAs in gynecological cancers: Small molecules with big implications.MicroRNA-mediated drug resistance in ovarian cancer.miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN.Platinum-Based Drugs Differentially Affect the Ultrastructure of Breast Cancer Cell Types.Modulation of chemoresponsiveness to platinum-based agents by microRNAs in cancer.A combination of circulating miRNAs for the early detection of ovarian cancer.Protective Effect of miR-374a on Chemical Hypoxia-Induced Damage of PC12 Cells In Vitro via the GADD45α/JNK Signaling Pathway.Molecular mechanisms of drug resistance in ovarian cancer.lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process.MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.Expression of miR-200a and chemotherapeutic treatment efficacy of glioma.Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
Q35850227-254956FC-E295-4A3D-BA58-33C56B179DFDQ36508613-D2203D50-5122-4603-832F-1F4F7B66146EQ36537367-3AB71E4A-DC17-4FCE-AEDC-1FC6D4528F25Q36917944-D9A743DC-9E70-46B0-8A0F-BCDCA310CEECQ37447892-A0D2A929-CF90-406D-9F71-66CCBCA0140AQ37732994-61FB178F-0702-4560-829B-6A3C5FCD8B57Q38447336-B5D0A0A2-87C5-4447-948C-9ADABEFF50C5Q38546133-6D20C98B-A96B-4D3F-8FAF-4851D3AFA67CQ38598439-09138AD2-704A-40CF-B0B6-2E4006B723DEQ38633144-F38C740E-1A5D-4123-85BD-8FCCEF99C815Q38695476-3CD7C82A-F908-4E39-801C-902E2E1A599AQ39287026-6BA82AEF-2A78-49F2-9892-C4B69A195910Q39333266-52263894-CDBE-4453-A96E-B61828AB18E5Q39382756-62EF444D-625F-4BB8-9E68-1BFB7D2BB0D9Q41143550-C00E6BF1-846F-4F3B-A1F4-A4ED18B3C8FCQ42076105-53910CB2-D3AB-4084-B8F7-2DCFFD029AF3Q42215256-B780F789-ED7A-4968-B9CD-1DD943E9FDA0Q45777871-F6F7D587-B1D0-437D-B000-DF426D90560CQ46238575-45BAA031-ACE6-41F3-BB9D-9B99CC4E9F31Q48274587-9588EBF1-A3A3-4C3F-B74D-B7DF530BC389Q49880961-894E1875-5A38-4F05-A925-F3E3F2D66DAFQ50047587-D5899E62-F413-4FD8-B860-F1FCC5FF7333Q50094397-EC75BD70-C1FD-4A27-9216-002A7828F7BAQ50133722-486C76F1-23D7-4804-9D0B-01725DC0487AQ50157919-2EAFF6F7-668A-45F0-9A85-165F53696DDCQ52679638-5FB4070D-0ADE-48AB-8E79-1EE4B04622CEQ54094631-231B30EC-28E8-421E-8901-D0C5B42BA601Q57471242-1ADF4D90-DC69-4D10-A212-9F1BA07293B3Q58694197-B762404B-921E-4A84-ADBD-F10AD0730DA2
P2860
MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@ast
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@en
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@nl
type
label
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@ast
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@en
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@nl
prefLabel
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@ast
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@en
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@nl
P2093
P2860
P1433
P1476
MiR-130a and MiR-374a Function ...... man Ovarian Cancer A2780 Cells
@en
P2093
Hongjing Wang
Lingyun Yang
Ningwei Li
Xibiao Jia
P2860
P304
P356
10.1371/JOURNAL.PONE.0128886
P407
P577
2015-01-01T00:00:00Z